Opportunity Information: Apply for RFA IP 09 004
Apply for RFA IP 09 004
- The Centers for Disease Control and Prevention in the health sector is offering a public funding opportunity titled "Research and Public Health Practice on Influenza and other respiratory infectious diseases in the Middle East, Southeast Asia, and South American regions" and is now available to receive applicants.
- Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.283 Centers for Disease Control and PreventionInvestigations and Technical Assistance.
- This funding opportunity was created on Jan 12, 2009 and posted on Dec 5, 2008.
- Applicants must submit their applications by Feb 19, 2009. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
- The funding agency has allocated a total of $15,000,000.00 to eligible and selected applicants.
- Each selected applicant is eligible to receive up to $3,000,000.00 in funding.
- The number of recipients for this funding is limited to 1 candidate(s).
- Eligible applicants include: Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled Additional Information on Eligibility.
[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:
Opportunity Summary:
The Centers for Disease Control and Prevention (CDC), through its Procurement and Grants Office, announced a discretionary funding opportunity titled "Research and Public Health Practice on Influenza and other respiratory infectious diseases in the Middle East, Southeast Asia, and South American regions" (Funding Opportunity Number RFA IP 09 004). The award mechanism is a cooperative agreement, which typically means CDC expects to have substantial involvement in the funded work through collaboration, technical input, and ongoing coordination rather than operating as a hands-off funder. The opportunity falls under the health activity category and is linked to CFDA 93.283 (CDC Investigations and Technical Assistance).
The main goal of this funding opportunity is to strengthen public health capacity in selected countries within the Middle East, Southeast Asia, and South America to better detect respiratory infectious diseases and to more clearly describe their epidemiology and disease burden. In practical terms, the program is designed to support work that improves surveillance and detection systems for influenza and other respiratory infections, generates stronger data on how these diseases spread and whom they affect, and produces evidence that can guide public health decisions. A second core emphasis is evaluating interventions, especially vaccines, by assessing their acceptability in local populations as well as measuring vaccine efficacy and real-world effectiveness. The announcement also allows for evaluation of other interventions against respiratory diseases, not just vaccines, reflecting an interest in both biomedical and public health practice approaches.
Funding details indicate that CDC expected to make one award, with approximately $3,000,000 available in fiscal year 2009 for that single recipient. While the award ceiling is listed as $3,000,000 and the award floor as $0, the larger estimated total funding amount in the source data is $15,000,000, which suggests the broader program may have been planned across multiple years or includes totals beyond the first year, even though only one award was anticipated. There is no cost-sharing or matching requirement, meaning applicants were not required to contribute non-federal funds as a condition of receiving the award.
Eligibility is described as unrestricted, meaning the competition was open to any type of entity as long as it met any additional eligibility clarifications in the full announcement. This kind of language typically allows applications from a wide range of organizations, such as universities, non-profits, research institutions, and potentially other qualified entities, depending on the detailed requirements and any geographic or partnership expectations spelled out in the full FOA.
Key dates for the opportunity include an initial posting date of December 5, 2008, with an original closing date of February 2, 2009, later extended to a current closing date of February 19, 2009. The archive date is March 4, 2009, indicating the opportunity was no longer active after that point. CDC anticipated an estimated funding date prior to July 1, 2009, giving applicants a general expectation of when decisions and awards would be made.
For applicants who needed the complete program details, CDC directed them to the FOA listing page on its website. The announcement also provided a practical support contact for access issues: PGO TIMS (phone 770-488-2700, with an email contact referenced for PGO TIMS), which is consistent with CDC practice of offering technical assistance for retrieving or viewing federal funding announcements.
Frequently Asked Questions (FAQs)
What is the title of this CDC funding opportunity?
The opportunity is titled "Research and Public Health Practice on Influenza and other respiratory infectious diseases in the Middle East, Southeast Asia, and South American regions."
What is the Funding Opportunity Number (FON)?
The Funding Opportunity Number is RFA IP 09 004.
Which federal agency is offering this grant?
The opportunity was announced by the Centers for Disease Control and Prevention (CDC) through its Procurement and Grants Office.
What type of award mechanism is being used?
The award mechanism is a cooperative agreement.
What does a cooperative agreement imply about CDC's role?
A cooperative agreement typically means CDC expects substantial involvement in the funded work. That can include collaboration, technical input, and ongoing coordination, rather than operating as a hands-off funder.
What program area or activity category does this opportunity fall under?
This opportunity falls under the health activity category.
What CFDA number is associated with this opportunity?
The opportunity is linked to CFDA 93.283 (CDC Investigations and Technical Assistance).
What is the main goal of this funding opportunity?
The main goal is to strengthen public health capacity in selected countries in the Middle East, Southeast Asia, and South America to better detect respiratory infectious diseases and to more clearly describe their epidemiology and disease burden.
What kinds of diseases are the focus of this program?
The program focuses on influenza and other respiratory infectious diseases.
Which regions are targeted by the program?
The targeted regions are the Middle East, Southeast Asia, and South America.
What types of activities does the program aim to support?
Based on the description provided, the program aims to support work that improves surveillance and detection systems for influenza and other respiratory infections, generates stronger data on how these diseases spread and who they affect, and produces evidence to guide public health decisions.
Does the opportunity include evaluation of interventions like vaccines?
Yes. A core emphasis is evaluating interventions, especially vaccines, including assessing acceptability in local populations and measuring vaccine efficacy and real-world effectiveness.
Are interventions other than vaccines included?
Yes. The announcement allows evaluation of other interventions against respiratory diseases, not only vaccines.
How many awards did CDC expect to make?
CDC expected to make one award.
How much funding was expected to be available?
CDC expected approximately $3,000,000 to be available in fiscal year 2009 for the single recipient.
What is the award ceiling?
The award ceiling is listed as $3,000,000.
What is the award floor?
The award floor is listed as $0.
Why is an estimated total funding amount of $15,000,000 mentioned?
The source data references an estimated total funding amount of $15,000,000, which suggests the broader program may have been planned across multiple years or includes totals beyond the first year, even though only one award was anticipated.
Is cost sharing or matching required?
No. There is no cost-sharing or matching requirement stated for this opportunity.
Who is eligible to apply?
Eligibility is described as unrestricted, meaning the competition was open to any type of entity, as long as it met any additional eligibility clarifications in the full announcement.
Does "unrestricted eligibility" mean any organization can apply?
It indicates the opportunity was broadly open to many types of organizations (for example, universities, non-profits, and research institutions), subject to any additional requirements or clarifications that may have been included in the full FOA.
When was the opportunity first posted?
The initial posting date was December 5, 2008.
What was the original application closing date?
The original closing date was February 2, 2009.
Was the deadline extended?
Yes. The closing date was extended to February 19, 2009.
What does the archive date mean for applicants?
The archive date is March 4, 2009, indicating the opportunity was no longer active after that point.
When did CDC expect funding decisions or awards to be made?
CDC anticipated an estimated funding date prior to July 1, 2009.
Where were applicants directed to find the complete program details?
Applicants were directed to the FOA listing page on the CDC website for complete program details.
Who should be contacted for help accessing the FOA?
For access issues, the announcement provided a support contact: PGO TIMS at 770-488-2700 (with an email contact also referenced for PGO TIMS).
Is the contact listed for programmatic questions or technical access issues?
Based on the description provided, PGO TIMS was listed as a practical support contact for access issues related to retrieving or viewing federal funding announcements.
Browse more opportunities from the same agency: Centers for Disease Control and Prevention
Browse more opportunities from the same category: Health
Next opportunity: Academic Research Enhancement Award (R15)
Previous opportunity: Influenza and Other Emerging Infectious Diseases in Vietnam (U01)
USGrants.org Applicant Portal:
Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.
Apply for RFA IP 09 004
[Watch] how do funding administrators access proposals?
Applicants also applied for:
Applicants who have applied for this opportunity (RFA IP 09 004) also looked into and applied for these:
| Funding Opportunity |
|---|
| Academic Research Enhancement Award (R15) Apply for PA 06 042 Funding Number: PA 06 042 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| NIDCD Patient Oriented Research Grant (R21) Apply for PA 06 086 Funding Number: PA 06 086 Agency: National Institutes of Health Category: Health Funding Amount: $200,000 |
| NIDCR Small Research Grants for Data Analysis and Statistical Methodology (R03) Apply for PAR 06 211 Funding Number: PAR 06 211 Agency: National Institutes of Health Category: Health Funding Amount: $100,000 |
| Retirement Economics (R03) Apply for PA 06 235 Funding Number: PA 06 235 Agency: National Institutes of Health Category: Health Funding Amount: $50,000 |
| Retirement Economics (R21) Apply for PA 06 236 Funding Number: PA 06 236 Agency: National Institutes of Health Category: Health Funding Amount: $200,000 |
| Ancillary Studies to the AD Neuroimaging Initiative (R03) Apply for PA 06 240 Funding Number: PA 06 240 Agency: National Institutes of Health Category: Health Funding Amount: $50,000 |
| Ancillary Studies to the Ad Neuroimaging Initiative (R21) Apply for PA 06 241 Funding Number: PA 06 241 Agency: National Institutes of Health Category: Health Funding Amount: $200,000 |
| Aging Musculoskeletal and Skin Extracellular Matrix (R21) Apply for PA 06 242 Funding Number: PA 06 242 Agency: National Institutes of Health Category: Health Funding Amount: $200,000 |
| From Intervention Development to Services Exploratory Research Grants (R34) Apply for PAR 06 248 Funding Number: PAR 06 248 Agency: National Institutes of Health Category: Health Funding Amount: $225,000 |
| Rapid Assessment Post Impact of Disaster (R03) Apply for PAR 06 252 Funding Number: PAR 06 252 Agency: National Institutes of Health Category: Health Funding Amount: $50,000 |
| Rapid Assessment Post Impact of Disaster (R21) Apply for PAR 06 253 Funding Number: PAR 06 253 Agency: National Institutes of Health Category: Health Funding Amount: $200,000 |
| Grants for Alzheimers Disease Drug Discovery (R21) Apply for PAS 06 261 Funding Number: PAS 06 261 Agency: National Institutes of Health Category: Health Funding Amount: $200,000 |
| Temporomandibular Joint and Muscle Disorders Pathophysiological Mechanisms Linking Comorbid Conditions (R03) Apply for PA 06 267 Funding Number: PA 06 267 Agency: National Institutes of Health Category: Health Funding Amount: $50,000 |
| Temporomandibular Joint and Muscle Disorders Pathophysiological Mechanisms Linking Comorbid Conditions (R21) Apply for PA 06 268 Funding Number: PA 06 268 Agency: National Institutes of Health Category: Health Funding Amount: $200,000 |
| NEI Research Grant for Secondary Data Analysis (R21) Apply for PAR 06 326 Funding Number: PAR 06 326 Agency: National Institutes of Health Category: Health Funding Amount: $200,000 |
| Womens Mental Health and Sex/Gender Differences Research (R21) Apply for PA 06 334 Funding Number: PA 06 334 Agency: National Institutes of Health Category: Health Funding Amount: $200,000 |
| Planning Grants For Translational Research For The Prevention And Control Of Diabetes And Obesity (R34) Apply for PAR 06 358 Funding Number: PAR 06 358 Agency: National Institutes of Health Category: Health Funding Amount: $150,000 |
| Cell Lineage and Developmental Studies in Hearing and Balance (R21) Apply for PA 06 365 Funding Number: PA 06 365 Agency: National Institutes of Health Category: Health Funding Amount: $200,000 |
| Proteomics in Auditory Developmental and Disease Processes (R21) Apply for PA 06 366 Funding Number: PA 06 366 Agency: National Institutes of Health Category: Health Funding Amount: $200,000 |
| NIAID Clinical Trial Planning (R34) Grants Apply for PAR 06 384 Funding Number: PAR 06 384 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
Grant application guides and resources
It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!
Apply for Grants
Premium leads for funding administrators, grant writers, and loan issuers
Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.
If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.
Subscribe to Leads
Request more information:
Would you like to learn more about this funding opportunity, similar opportunities to "RFA IP 09 004", eligibility, application service, and/or application tips? Submit an inquiry below:
Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.